Comparison

Lazabemide European Partner

Manufacturer MedChem Express
Category
Type Inhibitors
Specific against other
Clone N/A
Amount 10mM/1mL
Item no. HY-14201-10mM
Targets Monoamine Oxidase
CASRN 103878-84-8
eClass 6.1 30220300
eClass 9.0 32160605
Available
Product Description
Lazabemide (Ro 19-6327) is a selective, reversible inhibitor of monoamine oxidase B (MAO-B) (IC50=0.03 μM) but less active for MAO-A (IC50>100 μM). Lazabemide  inhibits monoamine uptake at high concentrations, the IC50 values are 86 μM, 123 μM and >500 μM for noradrenalin, serotonin and dopamine uptake, respectively. Lazabemide can be used for the research of parkinson and alzheimer′s disease[1].
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
Manufacturers Applications
Neuroscience-Neuromodulation
MolecularWeight
199.64
Clinical_Information
No Development Reported
Manufacturers Research_Area
Neurological Disease
Solubility
DMSO : 5 mg/mL (ultrasonic)
Manufacturers Target
Monoamine Oxidase
Pathway
Neuronal Signaling
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10mM/1mL
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close